The importance of ANGPTL4 in the regulation of plasma TG in humans is supported by human genetics indicating that loss-of-function variants in ANGPTL4 are associated with decreased plasma TG levels and a reduced risk of ASCVD (22, 23, 24, 25, 26). Here, ANGPTL4 is linked to atherosclerosis.